| Factor Information | |
|---|---|
| Data ID | 2956 |
| Factor | PIGF(placental growth factor) |
| Description | N/A |
| Biomarker | YES |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | endothelial markers in CHD children with PAH |
| p Value | 0.02 |
| Conclusion | The PlGF level, described as both a regenerative marker and an inflammatory marker, was higher in irreversible PAH(P= 0.02, t test after log-transformed data) |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 138 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 20195855 |
| Year | 2010 |
| Title | Comparison of Endothelial Biomarkers According to Reversibility of Pulmonary Hypertension Secondary to Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | patients' data | |
| Region | Paris, France | |
| Method | t test after log-transformed | |
| Race | French | |
| Disease History | pulmonary hypertension | |
| Treatment History | cardiac catheterization | |
| Group | CHD children with irreversible PAH(Treatment) | CHD children with reversible PAH(Control) |
| Number | 20.8(13.8-31.3) | 10.3(7.2-14.7) |
| Age | median age=9 years | median age=2 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 20.8(range:13.8-31.8, children CHD patients with irreversible PAH) | 10.3(range:7.2-14.7, children CHD patients with reversible PAH) |
